Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

NCT03161496 is registered in ClinicalTrials.gov with Cui Yimin as lead sponsor.

NCT NCT03161496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03161496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
Lead sponsor
Cui Yimin
Phase
Observational
Overall status
Unknown status
Start date
June 6, 2017
Completion date
December 31, 2021
Enrollment
1,200 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

accurate medication, apixaban, dabigatran, noacs, novel oral anticoagulants, pharmacodynamics, pharmacogenomics, pharmacokinetics, rivaroxaban